Scaffold thrombosis after percutaneous coronary intervention with ABSORB bioresorbable vascular scaffold: a systematic review and meta-analysis
MJ Lipinski, RO Escarcega, NC Baker, HA Benn… - JACC: Cardiovascular …, 2016 - jacc.org
Objectives: The aim of this study was to determine the risk of scaffold thrombosis (ST) after
percutaneous coronary intervention (PCI) with placement of an ABSORB bioresorbable …
percutaneous coronary intervention (PCI) with placement of an ABSORB bioresorbable …
An updated comprehensive meta-analysis of bivalirudin vs heparin use in primary percutaneous coronary intervention
R Shah, KC Rogers, K Matin, R Askari, SV Rao - American heart journal, 2016 - Elsevier
Background Despite several randomized controlled trials and meta-analyses, the ideal
anticoagulant for patients undergoing primary percutaneous coronary intervention (PCI) …
anticoagulant for patients undergoing primary percutaneous coronary intervention (PCI) …
Comparison of heparin, bivalirudin, and different glycoprotein IIb/IIIa inhibitor regimens for anticoagulation during percutaneous coronary intervention: a network meta …
MJ Lipinski, RC Lee, MA Gaglia Jr, R Torguson… - Cardiovascular …, 2016 - Elsevier
Abstract Background/purpose Numerous GPIs are available for PCI. Although they were
tested in randomized controlled trials, a comparison between the different GPI strategies is …
tested in randomized controlled trials, a comparison between the different GPI strategies is …
Periprocedural antithrombotic strategies in acute coronary syndromes undergoing percutaneous coronary intervention: Have we discarded bivalirudin too soon?
S Benenati, GL De Maria, F Della Mora… - Cardiovascular …, 2023 - Elsevier
Background Publication of the BRIGHT-4 trial results has restimulated discussion about the
optimal periprocedural antithrombotic strategy for patients undergoing percutaneous …
optimal periprocedural antithrombotic strategy for patients undergoing percutaneous …
2014 年心血管病学重要临床进展
崔炜 - 临床荟萃, 2015 - huicui.hebmu.edu.cn
2014 年心血管病学重要临床进展 Page 1 ·年度进展· 通信作者:崔炜,Email:cuiwei21 c@1 63.com
2014 年心血管病学重要临床进展 崔炜 (河北医科大学第二医院河北省心脑血管病研究所心内一科 …
2014 年心血管病学重要临床进展 崔炜 (河北医科大学第二医院河北省心脑血管病研究所心内一科 …
Incorporating linked healthcare claims to improve confounding control in a study of in-hospital medication use
JM Franklin, W Eddings, S Schneeweiss, JA Rassen - Drug safety, 2015 - Springer
Abstract Introduction The Premier Perspective hospital billing database provides a
promising data source for studies of inpatient medication use. However, in-hospital …
promising data source for studies of inpatient medication use. However, in-hospital …
[HTML][HTML] Risk guided use of the direct thrombin inhibitor bivalirudin: insights from recent trials and analyses
WB Hillegass, GS Bradford - Journal of Thoracic Disease, 2016 - ncbi.nlm.nih.gov
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2016; 8 (9): E1034-E1040
jtd. amegroups. com routine IIb/IIIa use, acute (< 24 hours) stent thrombosis was …
jtd. amegroups. com routine IIb/IIIa use, acute (< 24 hours) stent thrombosis was …
Новые антикоагулянты в лечении больных, недавно перенесших острый коронарный синдром. Место ривароксабана
ВН Хирманов - Кардиология, 2015 - elibrary.ru
В современном мире смерть чаще всего (примерно в каждом третьем случае)
обусловлена неблагоприятным течением ишемической болезни сердца …
обусловлена неблагоприятным течением ишемической болезни сердца …
Reduced-dose without the post-procedure infusion of bivalirudin in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention
Q Wang, T Zhou, L Yang, J Li, Q Zhang, X Wang - 2023 - researchsquare.com
Introduction: In clinical practice, the dose of bivalirudin may not be fully applicable to the
Chinese population. Therefore, this study aimed to explore the efficacy and safety of a …
Chinese population. Therefore, this study aimed to explore the efficacy and safety of a …
[PDF][PDF] Bivalirudin bewilderment
Percutaneous coronary intervention (PCI) with drug-eluting stents (DES) provides effective
revascularisation for many patients with coronary artery disease (CAD)[1]. Appropriate …
revascularisation for many patients with coronary artery disease (CAD)[1]. Appropriate …